Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Partial Knee Resurfacing System Offers Reduced Hospital Stays

By HospiMedica staff writers
Posted on 24 Apr 2008
A partial knee resurfacing system with advanced bearing technology helps to restore normal physiologic ligament tension and knee kinematics throughout the range of motion.

The Stryker Triathlon partial knee resurfacing (PKR) system was designed to make unicompartmental knee resurfacing (UKR) potentially easier and more straightforward. More...
The Triathlon PKR is a fixed bearing unicompartmental or unicondylar knee that blends a measured resection system with a gap balancing system. The bone-preserving approach eliminates the need to violate the intramedullary (IM) canal, and provides the potential to return patients back to their normal activities. A patented single radius design (designed to provide ligament stability through the range of motion), coupled with the ability to balance the flexion and extension gaps, is intended to produce more stable, natural knee motion. The Triathalon PKR utilizes proprietary X3 advanced crosslinked bearing technology. The device is also anatomically shaped, with the femoral component featuring a 7.5 degree bend to match the natural curve of the femoral condyle, designed to enable surgeons to use advanced minimally invasive surgical techniques, which may result in a smaller scar for the patient. The femoral component can withstand up to +/- 10 degrees of misalignment without edge loading. The Stryker PKR is a product of Stryker (Kalamazoo, MI, USA).

"Triathlon PKR with X3 is a great addition to the Triathlon Knee family, which allows surgeons to treat the unique needs of each patient and provide them with a personalized solution,” said Mike Mogul, president of Stryker Orthopedics.

Potential benefits of PKR include a quicker operation, performed on an outpatient basis. Additionally, less bone is removed and there is often less trauma to soft tissue during surgery, which may leave the patient with a more natural feeling knee than with a total knee replacement.


Related Links:
Stryker

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.